Skip to content 
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. more
| Time Frame | INCR | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -6.39% | 0.9% | 1.15% |
| 1-Month Return | 9.19% | -0.85% | 8.2% |
| 3-Month Return | -8.89% | -6.95% | 8.86% |
| 6-Month Return | -40.15% | -3.95% | 10.42% |
| 1-Year Return | -46.41% | 11.25% | 26.5% |
| 3-Year Return | -68.22% | 11.18% | 79.84% |
| 5-Year Return | -87.19% | 19.44% | 80.93% |
| 10-Year Return | -92.66% | 112.19% | 263.45% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 219.68M | 388.68M | 355.55M | 238.84M | 270.20M | [{"date":"2021-12-31","value":56.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.48,"profit":true},{"date":"2024-12-31","value":61.45,"profit":true},{"date":"2025-12-31","value":69.52,"profit":true}] |
| Cost of Revenue | 128.55M | 233.60M | 250.46M | 208.61M | 237.02M | [{"date":"2021-12-31","value":51.32,"profit":true},{"date":"2022-12-31","value":93.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":83.29,"profit":true},{"date":"2025-12-31","value":94.63,"profit":true}] |
| Gross Profit | 91.13M | 155.08M | 105.09M | 30.23M | 33.18M | [{"date":"2021-12-31","value":58.76,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.77,"profit":true},{"date":"2024-12-31","value":19.49,"profit":true},{"date":"2025-12-31","value":21.4,"profit":true}] |
| Gross Margin | 41.48% | 39.90% | 29.56% | 12.66% | 12.28% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.18,"profit":true},{"date":"2023-12-31","value":71.25,"profit":true},{"date":"2024-12-31","value":30.51,"profit":true},{"date":"2025-12-31","value":29.6,"profit":true}] |
| Operating Expenses | 62.95M | 104.46M | 146.66M | 97.44M | 26.45M | [{"date":"2021-12-31","value":42.92,"profit":true},{"date":"2022-12-31","value":71.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":66.44,"profit":true},{"date":"2025-12-31","value":18.03,"profit":true}] |
| Operating Income | 28.19M | 50.63M | (41.57M) | (67.21M) | 6.73M | [{"date":"2021-12-31","value":55.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-82.1,"profit":false},{"date":"2024-12-31","value":-132.75,"profit":false},{"date":"2025-12-31","value":13.3,"profit":true}] |
| Total Non-Operating Income/Expense | (14.37M) | (20.63M) | (39.39M) | (40.21M) | (69.11M) | [{"date":"2021-12-31","value":-1436600000,"profit":false},{"date":"2022-12-31","value":-2063000000,"profit":false},{"date":"2023-12-31","value":-3939000000,"profit":false},{"date":"2024-12-31","value":-4020700000,"profit":false},{"date":"2025-12-31","value":-6911400000,"profit":false}] |
| Pre-Tax Income | 18.74M | 43.84M | (61.28M) | (87.32M) | (44.10M) | [{"date":"2021-12-31","value":42.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-139.79,"profit":false},{"date":"2024-12-31","value":-199.18,"profit":false},{"date":"2025-12-31","value":-100.6,"profit":false}] |
| Income Taxes | 11.44M | 93.00K | 2.25M | (14.53M) | (7.32M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.81,"profit":true},{"date":"2023-12-31","value":19.65,"profit":true},{"date":"2024-12-31","value":-127,"profit":false},{"date":"2025-12-31","value":-63.97,"profit":false}] |
| Income After Taxes | 7.30M | 43.75M | (63.53M) | (72.79M) | (36.78M) | [{"date":"2021-12-31","value":16.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-145.22,"profit":false},{"date":"2024-12-31","value":-166.39,"profit":false},{"date":"2025-12-31","value":-84.08,"profit":false}] |
| Income From Continuous Operations | 7.30M | 43.75M | (63.53M) | (72.79M) | (36.78M) | [{"date":"2021-12-31","value":16.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-145.22,"profit":false},{"date":"2024-12-31","value":-166.39,"profit":false},{"date":"2025-12-31","value":-84.08,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 4.69M | 44.82M | (61.96M) | (67.80M) | (35.71M) | [{"date":"2021-12-31","value":10.46,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-138.24,"profit":false},{"date":"2024-12-31","value":-151.26,"profit":false},{"date":"2025-12-31","value":-79.68,"profit":false}] |
| EPS (Diluted) | - | 1.04 | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| INCR | |
|---|---|
| Cash Ratio | 0.22 |
| Current Ratio | 1.48 |
| Quick Ratio | 0.97 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| INCR | |
|---|---|
| ROA (LTM) | -2.19% |
| ROE (LTM) | -9.27% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| INCR | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.43 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.57 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| INCR | |
|---|---|
| Trailing PE | NM |
| Forward PE | 6.18 |
| P/S (TTM) | 0.48 |
| P/B | 0.34 |
| Price/FCF | 10 |
| EV/R | 1.00 |
| EV/Ebitda | 5.29 |
InterCure Ltd. (INCR) share price today is $0.823
Yes, Indians can buy shares of InterCure Ltd. (INCR) on Vested. To buy
Yes, you can purchase fractional shares of InterCure Ltd. (INCR) via the Vested app. You can start investing in InterCure Ltd. (INCR) with a minimum investment of $1.
You can invest in shares of InterCure Ltd. (INCR) via Vested in three simple steps:
The 52-week high price of InterCure Ltd. (INCR) is $1.77. The 52-week low price of InterCure Ltd. (INCR) is $0.68.
The price-to-earnings (P/E) ratio of InterCure Ltd. (INCR) is
The price-to-book (P/B) ratio of InterCure Ltd. (INCR) is 0.34
The dividend yield of InterCure Ltd. (INCR) is 0.00%
The market capitalization of InterCure Ltd. (INCR) is $44.84M
The stock symbol (or ticker) of InterCure Ltd. is INCR
Consider the share price of InterCure Ltd. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether InterCure Ltd. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in InterCure Ltd. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the InterCure Ltd. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of InterCure Ltd. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that InterCure Ltd. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
